Colon Adenocarcinoma Quantitative Proteomics Reveals Dysregulation in Key Cancer Signaling Pathways and a Candidate Protein Marker Panel
- 1 February 2023
- journal article
- research article
- Published by Mary Ann Liebert Inc in OMICS: A Journal of Integrative Biology
- Vol. 27 (2), 75-85
- https://doi.org/10.1089/omi.2022.0169
Abstract
Colorectal cancer (CRC) is reportedly the second leading cause of cancer death worldwide. By the end of the decade, there will likely be more than one million fatalities worldwide from this cancer, with an estimated 2.2 million additional cases. We need new ways of thinking about cancer research. One approach is to deploy systems science using quantitative proteomics to obtain postgenomic and functional insights into cancer. The present study compares the tissue proteome of CRC (n = 10) with the matched peritumoral controls (n = 10) in samples obtained from the Indian subcontinent. When compared with the controls, a list of 22 substantially altered protein candidates was identified, which were associated with the growth, survival, and metastasis of the tumor. A list of the unique peptides from top significant proteins, including olfactomedin-4, alanyl aminopeptidase, and grancalcin was further validated using a parallel reaction monitoring-based targeted proteomics approach. In addition, biological pathway analysis showed perturbation in key biological processes, including dysregulation in purine metabolism, MYC targets in cancer, DNA repair, and replication, and leukocyte transendothelial migration, among others. The protein panel reported herein is also shown to be dysregulated in CRC and warrants further research toward understanding pathobiology, diagnostics, and therapeutics development in CRC.Keywords
This publication has 24 references indexed in Scilit:
- O-GlcNAcylation of YY1 stimulates tumorigenesis in colorectal cancer cells by targeting SLC22A15 and AANATCarcinogenesis: Integrative Cancer Research, 2019
- Colorectal Cancer in India: An Audit from a Tertiary Center in a Low Prevalence AreaIndian Journal of Surgical Oncology, 2017
- OLFM4, KNG1 and Sec24C identified by proteomics and immunohistochemistry as potential markers of early colorectal cancer stages.Clinical Proteomics, 2017
- Grancalcin (GCA) modulates Toll‐like receptor 9 (TLR9) mediated signaling through its direct interaction with TLR9European Journal of Immunology, 2015
- Colorectal cancer diagnosis: Pitfalls and opportunitiesWorld Journal of Gastrointestinal Oncology, 2015
- Altered glutamyl-aminopeptidase activity and expression in renal neoplasmsBMC Cancer, 2014
- Prognostic significance of aberrantly silenced ANPEP expression in prostate cancerBritish Journal of Cancer, 2013
- Depletion of OLFM4 gene inhibits cell growth and increases sensitization to hydrogen peroxide and tumor necrosis factor-alpha induced-apoptosis in gastric cancer cellsJournal of Biomedical Science, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Aminopeptidase N (CD13) as a target for cancer chemotherapyCancer Science, 2011